Sam Gandy, Valérie Bonnelle and moreMay 18, 20222 minDSPLPsychedelics as potential catalysts of scientific creativity and insightAuthors Sam Gandy, Valérie Bonnelle, Edward Jacobs, David Luke Published May 16, 2022 Abstract Creativity, that is the creation of ideas...
Drug ScienceMar 7, 20225 minMPWGTripping over red tape: psychedelics for mental healthThe last decade has seen a new focus on psychedelics as powerful medicines for treating severe mental health issues, including the use of...
Dr Carol RoutledgeFeb 11, 20226 minDMTWhat is DMT therapy?By Dr Carol Routledge, Chief Medical & Scientific Officer at Small Pharma DMT-assisted therapy is a novel psychedelic therapy which aims...
Dr Anne Schlag, Professor David Nutt and moreFeb 3, 20223 minMPWGAre psychedelics dangerous? - What the research saysAuthors Anne K Schlag, Jacob Aday, Iram Salam, Jo C Neill, David J Nutt Published February 3, 2022 Psychedelic medicines are a rapidly...
Annie Howard, Joanna Neill and moreOct 26, 20213 minDSPLSchedule 1 Barriers to Research in the UK: An In-depth Qualitative AnalysisAuthors Annie Howard, Joanna C Neill, Anne Katrin Schlag, Charlotte Lennox Published October 25, 2021 Prior to the 1970s, psychedelics...
Drug ScienceJun 4, 20217 minMPWGYouGov Results - Is the UK Ready to Reschedule Psilocybin?Summary Full Report Survey Data Does the UK support psilocybin research? Public perceptions of psilocybin-assisted therapy have been...
Jacob S Aday, Emily K Bloesch and moreNov 26, 20202 minDSPL2019: A year of expansion in psychedelic research, industry, and deregulation